Multiple Products in a Monoclonal Antibody S88.01 Batch Plant
|
|
- Dinah Jones
- 8 years ago
- Views:
Transcription
1 Presented at the World Batch Forum North American Conference Chicago, IL May 16-19, Fox Valley Drive, Suite 204 Longwood, FL Fax: Multiple Products in a Monoclonal Antibody S88.01 Batch Plant Mahasti Kheradmand Automation Supervisor Genentech 1000 New Horizons Way Vacaville, CA United States Phone Fax mkheradm@gene.com John O Connell Automation Supervisor Genentech 1000 New Horizons Way Vacaville, CA United States Phone Fax johno@gene.com KEY WORDS S88, Biotechnology, Monoclonal Antibody ABSTRACT The most successful biotech companies have multiple products approved for market and must make the use of existing manufacturing capacity to produce them. Often times this requires rapid changeover from one product to the next. This paper addresses the challenges with bringing new products into an existing S88.01 facility and the challenges involved in maintaining the standard as well as implementing a change in an operating plant with a minimum of downtime. It was found that the S88 concept is enormously helpful in implementing changes within the equipment capability but that challenges arise when the equipment capability must be changed also. The recommendation is to standardize the manufacturing process and build the necessary capability into the plant upfront to avoid costly downtime during product changeover. Copyright 2004 World Batch Forum. All rights reserved. Page 1
2 PAPER Introduction The S88 batch standards have been a tremendous benefit to the pharmaceutical industry. The standardized approach in the design of process equipment and control system software has dramatically reduced the effort required to design, construct and validate a batch manufacturing facility. With the increased number of marketed products, the market leaders in biotechnology are approaching the limits of their in-house manufacturing capacity. The net result is that existing plants are being required to produce multiple products and to switch as quickly as possible between production campaigns. For those companies fortunate enough to have newly approved products, there is an additional demand to quickly introduce the manufacture of new products into existing facilities. This paper explores some of the major aspects related to bringing a new manufacturing process on-line in an existing multi-product monoclonal antibody facility already automated to the S88 standard. Some thoughts on future directions for easing these difficulties in new plants are also offered. Process Background The typical monoclonal antibody facility includes a fermentation train that ranges from laboratory scale fermenters in the 10 to 20L scale to large scale cell culture vessels in the range of 10,000 to 20,000 liters. The cell culture vessels are held under controlled conditions of level, ph, agitation and dissolved oxygen in order to provide the optimal conditions for production of the molecule of interest by genetically engineered organisms. The facilities will also include a harvest system that is used to clarify the cell culture fluid as it is removed from large scale cell culture vessels at the end of a batch. The clarified harvest is typically further processed in a product recovery suite that includes one or more chromatography steps and final product formulation via ultrafiltration. Chromatography is used to purify the product by separating it under carefully controlled conditions from the clarified harvest. Both the cell culture and protein areas are serviced by preparation and storage tanks that provide and store growth media for the cell culture vessels and buffer solutions for the chromatography and ultrafiltration units. Most Changes Happen in Product Recovery Most of the changes from product to product occur in the recovery area as this is where the manufacturing process for monoclonal antibodies is most variable. It is very rare that major equipment changes need to be made in cell culture since this portion of the process has been somewhat standardized across the industry. The process variation can take the form of new production steps such as replacement of a chromatography step with a filtration step, new capability requirements such as inline dilution as part of a chromatography step or increased yield. Variations in yield can render the existing recovery process equipment to small or too large for the intended purpose. New process steps Copyright 2004 World Batch Forum. All rights reserved. Page 2
3 or equipment capabilities may require modification of existing recovery equipment. Both of these types of process changes may require plant downtime between products as both the equipment and the associated software will need to be modified and fully tested before the next production campaign can begin. Production campaign changeovers are usually much less trouble in the cell culture area. Since it is rare that new steps or capabilities need to be added, most new products can be introduce with recipe level changes only. This dramatically reduces the time spent defining requirements and developing software in cell culture as compared to recovery. As more products are added to the facility it becomes more difficult to make changes The complexity of a multi-product monoclonal anti-body plant tends to increase over time. For a single product plant only one set of conditions needs to be considered for every phase or control module that is added or changed in the plant. In a plant that supports six different products, the impact on each of these processes must be considered for every change. The level of design effort is increased as the changes become more complex and as the functional requirements differ between products. Piping and control schemes that would be relatively straight forward for a single product become more involved as the process requirements for each of the various products is built into the design. The net result is that as more capability and flexibility is added to the plant the design and implementation cycles will lengthen since any changes must preserve existing functionality while meeting the requirements of the new product. The overhead required to maintain the master recipes for all the products in a plant will increase with the number of products. The overhead required to maintain a library of master recipes increases with the number of supported products. All products have a particular set of processing requirements defined in their set of master recipes. As the number of products supported by a particular plant increases the number of master recipes associated with the plant also increases. Process model changes for any new product may invalidate existing master recipes requiring them to be revised before they are used again extending the project schedule. Depending on the complexity of the changes and the level of testing required, it may even take longer to revise the existing product recipes than it did to develop recipes for the new product or process. A large library of master recipes also tends to increase the time required to make routine changes to the plant. For a facility that supports multiple products it becomes more difficult to assess the impact of a particular change on all of the recipes. For example a recent project to introduce a new product required the development or modification of over 171 recipes 95 of which were existing product recipes. In addition, a process improvement change that is common for all products will require multiple edits in order to implement the change since each product will have its own set of master recipes. Copyright 2004 World Batch Forum. All rights reserved. Page 3
4 In the absence of general recipe, transferring a process from one site to the next can be very time consuming. For organizations that have multiple sites, transferring processes between facilities can be extremely challenging. This is particularly true if the two facilities have different control systems, equipment capabilities and/or business systems. In particular, process transfer between paper based and paperless facilities is very labor intensive without general or site recipes. In the absence of an enterprise wide information structure such as that defined by S88, it is necessary to convert the words and steps from paper based operator instructions to recipes, phase logic and control modules. An exhaustive verification is required to ensure that the critical process parameters and steps have been correctly coded into the recipes. For a complex process transfer, this verification can add several weeks to the design effort and require many hours of cross functional team meetings. Adopting the common data structure of a general recipe would speed this process up tremendously by quickly allowing the identification of the critical steps, equipment capabilities, process parameters and material requirements. Implementation of the S88 standard for general and site recipes requires an enterprise wide commitment and there may be some institutional resistance to expend the time and capital required to implement the concept. It would however be worth the investment since it can reduce the time it takes to move a production process between sites and as a result makes the manufacturing capacity of the organization more responsive and flexible. Planning is Essential for a Smooth Product Transfer It is essential that monoclonal antibody manufacturing firms adopt a plan to manage process to process variability if they are to maximize on the capability of existing facilities. Since it would be prohibitively expensive to build a plant that can run all of the current manufacturing processes for monoclonal antibodies most manufacturing plants can support a limited subset of these processes. Information about the existing manufacturing capabilities must be communicated to the process development staff. Often times the process developers have choices in the methods they select to manufacture and purify a new molecule. If they are aware of downstream constraints they are more likely to develop a method that will fit within the existing capabilities. At the very least they will be able to provide advance warning when changes will be required for an existing facility. The process development scientist must communicate the required manufacturing capabilities of the process equipment early in the process transfer effort. This is most conveniently done in a user requirements specification that forms the basis for both the process and control system design. Having well defined user requirements up front allows the project team to quickly assess whether a manufacturing site has the necessary capability to run a process or to determine what changes will be needed to support the new product. Planning for product to product process variation will allow the organization to more rapidly respond to required changes and maximize the use of existing manufacturing capacity. Minimizing Downtime Copyright 2004 World Batch Forum. All rights reserved. Page 4
5 Keeping plant downtime to a minimum is mandatory during a campaign changeover. Downtime in a manufacturing facility is never a good thing and since most monoclonal antibody plants run on a 24/7 basis it is also difficult to schedule. A successful product changeover with minimum downtime requires careful planning. Sufficient lead time should be allowed to get the requirements documents revised and to develop and test most of the software changes in an offline environment. Since downtime comes at such a premium, early involvement and training of persons performing debug is a must. Adequate staffing should be provided across all disciplines to allow around the clock coverage during the plant shutdown for all installation, debug and validation activities. Although detailed planning is a required, the project team must also be flexible enough to take advantage of opportunities to complete tasks ahead of schedule when debug and testing efforts go well in order to compensate for the time lost when they do not go as expected. The S88 standard is both a help and hindrance in the effort to minimize plant downtimes during campaign changeovers. The modular software structure of a S88 plant allows changeover lead times to be reduced because software objects such as phases and control modules that are used in multiple units can be modified and tested once in an offline environment and then copied to where they are used. For example, in a recent project over 31 control module instances had to be added to the configuration but since the control modules were designed to be portable between multiple units only 1 new control module had to be created. This reduced the level of effort required for software engineering of control modules by at least two orders of magnitude since there was no need to specify, develop and test the existing control modules that were being re-used. For product changeovers that do not require unit level changes, software development is limited to the creation of new master recipes. Designing software to the S88 standard reduces the downtime required to change from product to product by allowing the same code to be used on multiple units and multiple products with simple recipe parameter changes. The S88 standard can become a hindrance when adherence to the standard will require extra effort. For example it may be much quicker to solve a problem found during debug by modifying a control module on a single unit so that it is no longer portable to other similar units. In almost every case it is best to make the extra effort to comply with the standard since non-standard code will make plant harder to maintain in the long-term. Stay on Top of Change Control An important factor in minimizing plant downtime is managing the change control process. After requirements definition, most of the hours in a software development effort are spent developing and executing test plans. Doing this work correctly is essential for project success. Executing the change control process poorly by not following good documentation procedures, making unauthorized changes or taking short cuts on testing will increase the number of hours required to complete a project. In a regulated industry if the software development and testing is not done under proper change control it Copyright 2004 World Batch Forum. All rights reserved. Page 5
6 will normally take the involvement of department management and quality assurance to justify the deviation from the process. In some cases repeating the work may also be required and in all cases it will take much longer to correct an error than to follow the correct procedures.. Doing it right the first time is definitely worth the effort in the final quality of the software and the overall productivity of the project. Before a large implementation project begins it is best to get prepared to work under the change control system. The following steps will go a long when in getting your team ready: Review the change control process and streamline it where possible prior to the start of software development Refresh the team members understanding by conducting change control and configuration management training. Put an administrative assistant on the project to assist with managing and organizing the large volume of paper associated with software testing. Have a written configuration management plan and all the necessary tools in place to manage the software objects through development, testing and implementation. Review and close out tests and testing deviations as soon as possible following test execution. Doing this rapidly will allow testing issues to be documented and dealt with while the events are fresh in the memory of the parties involved. Applying Lessons Learned To A New Facility Designing a new facility presents the opportunity to avoid building in the limitations inherent in older concepts. With the pace of technological change in Monoclonal antibody manufacturing a new facility must have the ability to deal with increase yields and process changes by providing a scalable and flexible plant. This is especially true in the recovery area which is so sensitive to yield improvements and the area with the greatest product to product process variability. Consideration should be given to technologies such as buffer concentrates that increase the capacity of processing suites and the use of skid mounted recovery equipment that can be changed out quickly for a product change over. To help build in the required capabilities a user requirements specification should be developed for each process unit. The user requirement should specify the equipment capabilities that will be required to support all the products that the plant is intended to produce not just the product that the plant will begin to manufacture immediately after start-up. The process development staff needs to be fully engaged with engineering and manufacturing in the requirements development process because they are most fully aware of the manufacturing processes being considered for all the products in the pipeline. Involving them in the requirements definition also makes them aware of what the new plant will be capable of and having this document available will allow them to make more informed choices as they design the process for future products. Finally there should be a formal risk assessment considering the impact of emerging technologies as related to cell culture yield improvements and protein recovery operations. Asking the what if questions up front can allow some level of risk mitigation to be built into the plant and reduce costly downtime and changes over the life time of the plant as new technologies are employed. Copyright 2004 World Batch Forum. All rights reserved. Page 6
7 What s Ahead in Monoclonal Antibody Manufacturing? According to the BIO Editor s and Reporter s Guide published by the Biotechnology Industry Organization there were 35 new Biotech drugs and vaccines approved for market in 2002 and there are more than 370 new Biotech drugs in clinical trials. It has also been speculated that the current industry standard yield for a CHO based monoclonal antibody cell culture process may triple from 1 g/l to 3 g/l and this will require continued innovation in the product recovery technology downstream of cell culture (Gottshalk). Plants designed for the 1 g/l scale will be challenged to take full benefit of these yield improvements and new facilities must be both scalable and flexible to accommodate product to product yield changes and evolving technology. With the large number of products in the pipeline, those monoclonal antibody manufacturing firms that can deal best with multiple products, fast product changeovers, improved yields and evolving technology will have a key advantage over their competitors. Copyright 2004 World Batch Forum. All rights reserved. Page 7
8 Sources Cited Biotechnology Industry Association. Bio Editor s and Reporter s Guide , June 2003, 02 Mar 2004 < Gottshalk, Uwe. Biotech Manufacturing is Coming of Age. Bioprocess International April 10, Mar 2004 < Copyright 2004 World Batch Forum. All rights reserved. Page 8
Eden Biodesign ebook Monoclonal Antibody Production: Building the Platform
Eden Biodesign ebook Monoclonal Antibody Production: Building the Platform CHAPTER 1: Overview CHAPTER 2: Challenges CHAPTER 3: Purification Methodology CHAPTER 4: Results CHAPTER 5: About Eden Biodesign
More informationAdvances in Biopharmaceutical and Vaccine Manufacturing Plants
Hitachi Review Vol. 62 (2013), No. 4 267 Advances in Biopharmaceutical and Vaccine Manufacturing Plants Sei Murakami, Dr. Eng. Haruo Suzuki Keisuke Shibuya, Dr. Sc. OVERVIEW: The development of innovative
More informationEconomical Approaches to Meeting Global Demand for High Value Biopharmaceuticals
Economical Approaches to Meeting Global Demand for High Value Biopharmaceuticals Howard L. Levine and Susan Dana Jones BPI Europe 2013 Apr 17-18, 2013 Dusseldorf, Germany BioProcess Technology Consultants
More informationHow single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs
WHITE PAPER 7004 How single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs By John Boehm Business Unit Manager Colder Products Company Today s
More informationLFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals
LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals MAbLaunch TM is a joint bioproduction platform combining LFB Biomanufacturing (LFB
More informationBiomanufacturing Vision for the Future
Biomanufacturing Vision for the Future Shou-Bai Chao, Ph.D. Senior Vice President Global Manufacturing and Technical Operations MedImmune (a Div of AstraZeneca) NIPTE/FDA Research Conference Future of
More informationMab manufacturing today and tomorrow. Reducing risk, reducing cost. Reducing costs, informing decisions, insight for innovation.
Mab manufacturing today and tomorrow. Reducing risk, reducing cost. Reducing costs, informing decisions, insight for innovation. Summary Monoclonal antibodies are expensive to develop and to manufacture.
More informationPharma & Biotech processes: global turnkey solutions
Pharma & Biotech processes: global turnkey solutions 02 Our mission: to design and build turnkey process solutions AS A LEADING-EDGE INDUSTRIAL INTEGRA- TOR, BOCCARD DESIGNS AND BUILDS UNIQUE PHARMACEUTICAL
More informationOne of the greatest challenges facing biopharmaceutical
Monoclonal Antibody Manufacturing Strategies for the 21st Century James Blackwell, Ph.D., MBA Sr. Consultant Thomas Ransohoff, VP and Sr. Consultant Howard L. Levine, Ph.D., President and Principal Consultant
More informationProcess Simulation and Modeling Strategies for the Biotechnology Industry
Process Simulation and Modeling Strategies for the Biotechnology Industry Optimizing Productivity in Multiproduct Batch Facilities Ian Gosling, Ph.D. www.chemsim.com Process simulation and modeling is
More informationPlantForm Corporation
PlantForm Corporation Professor J. Christopher Hall CSO PlantForm Corporation Canada s Top10 Winner Life Sciences 2008/9 Innovator of the Year Guelph, Canada, 2010 Opportunity The introduction of more
More informationContract No: Disclaimer:
Contract No: This document was prepared in conjunction with work accomplished under Contract No. DE-AC09-09SR22505 with the U.S. Department of Energy (DOE) National Nuclear Security Administration (NA).
More informationSingle-Use Bioreactors Meeting BioPharma Needs for Lower Operating Cost and Faster Time to Market
Single-Use Bioreactors Meeting BioPharma Needs for Lower Operating Cost and Faster Time to Market White Paper White Paper Single-use bioreactors meeting biopharma needs for lower operating cost and faster
More informationLFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals
LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals MAbLaunch TM is a joint bioproduction platform combining LFB Biomanufacturing (LFB
More informationAgile Project Execution
ebook Agile Project Execution The future of Industrial Process Automation projects v1.4 EMK(VDS)-TR-EB-01 APEX ebook Table of Contents Intro Agile Project Execution Page 2. Chapter 1 Conventional Project
More informationA World of Biomanufacturing: Shortages or Global Glut?
A World of Biomanufacturing: Shortages or Global Glut? Howard L. Levine, Ph.D. BioProcess Technology Consultants, Inc. BioProcess International Conference Vienna, Austria May 19-20, 2010 Steady growth
More informationCDC UNIFIED PROCESS JOB AID
CDC UNIFIED PROCESS JOB AID Independent Verification & Validation Activities Document Purpose This Job Aid is a brief document listing the items to be noted, checked, remembered, and delivered when completing
More informationAdvancements in Modularization
Advancements in Modularization Standardization, Modular Unit Operations and Global Deployment Interphex 2013 New York, NY Pär Almhem President ModWave & ModularPartners Outline Introduction to Modularization
More informationEnd-to-End E-Clinical Coverage with Oracle Health Sciences InForm GTM
End-to-End E-Clinical Coverage with InForm GTM A Complete Solution for Global Clinical Trials The broad market acceptance of electronic data capture (EDC) technology, coupled with an industry moving toward
More informationWonderware InBatch. Flexible batch management
Flexible batch management Wonderware InBatch is control system independent software that can be used for the most complex batching processes that require a high level of flexibility. Sophisticated equipment
More informationIntroducing: BioXpert. Supervisory Control and Data Acquisition Software
Introducing: BioXpert Supervisory Control and Data Acquisition Software Applikon Biotechnology SUPERVISORY CONTROL AND DATA ACQUISITION SOFTWARE BioXpert Introducing: BioXpert BioXpert is a software tool
More informationORACLE CLINICAL. Globalization. Flexibility. Efficiency. Competition ORACLE DATA SHEET OVERVIEW ROBUST CLINICAL DATA MANAGEMENT SOLUTION
ORACLE CLINICAL OVERVIEW ROBUST CLINICAL DATA MANAGEMENT SOLUTION Smoothly transition from paper to EDC trials Annotated CRFs provides an intuitive means of creating submission-ready annotations Improved
More informationConsiderations for Management of Laboratory Data
Considerations for Management of Laboratory Data 2003 Scientific Computing & Instrumentation LIMS Guide, November 2003 Michael H Elliott Drowning in a sea of data? Nervous about 21 CFR Part 11? Worried
More informationb-comm ERP 5 - SAP ERP An Automated Solution for Time and Attendance, Access Control, and Shop Floor Data Collection Data Collection ERP Integration
b-comm ERP 5 - SAP ERP An Automated Solution for Time and Attendance, Access Control, and Shop Floor Data Collection Data Collection ERP Integration 2 Index Kaba s b-comm ERP 5 - SAP Solution Kaba as Your
More informationESTABLISHING A MEASUREMENT PROGRAM
ESTABLISHING A MEASUREMENT PROGRAM The most important rule is to Understand that software measurement is a means to an end, not an end in itself Three key reasons for Software Measurement Understanding
More informationMaximizing return on plant assets
Maximizing return on plant assets Manufacturers in nearly every process industry face the need to improve their return on large asset investments. Effectively managing assets, however, requires a wealth
More informationBiotechpharma company profile
Biotechpharma company profile October 2013 1 History 2004 Biotechpharma UAB established as a proteomic research company in Vilnius, Lithuania 2005 Company became a member of UK s Northway group, investing
More informationWHY CONTRACTORS AUTOMATE TIME AND ATTENDANCE
WHY CONTRACTORS AUTOMATE TIME AND ATTENDANCE FROM A LEADER IN WORKFORCE MANAGEMENT SOLUTIONS www.mitcsoftware.com INTRODUCTION Labor costs are the largest controllable expense for most contractors. Contractors
More informationUse of the ambr 250 in combination with high-throughput design and analysis tools for rapid, scalable USP development
Use of the ambr 250 in combination with high-throughput design and analysis tools for rapid, scalable USP development Authors: Dr Fern Slingsby and Dr Simon Dewar Upstream Process Development FUJIFILM
More informationDell Reliable Memory Technology
Dell Reliable Memory Technology Detecting and isolating memory errors THIS WHITE PAPER IS FOR INFORMATIONAL PURPOSES ONLY, AND MAY CONTAIN TYPOGRAPHICAL ERRORS AND TECHNICAL INACCURACIES. THE CONTENT IS
More informationHow Do Field Interviewers Measure Time?
An App to Facilitate Real Time Reporting of Interviewer Activities: Revelations and Outcomes of a Beta Test Catherine Haggerty 1, Kymn Kochanek 1, and Micah Sjoblom 1 1 First through third Author s Affiliation,
More informationJOURNAL OF OBJECT TECHNOLOGY
JOURNAL OF OBJECT TECHNOLOGY Online at http://www.jot.fm. Published by ETH Zurich, Chair of Software Engineering JOT, 2006 Vol. 5, No. 6, July - August 2006 On Assuring Software Quality and Curbing Software
More informationMAKE THE SWITCH TO ELECTRONIC DATA CAPTURE
MAKE THE SWITCH TO ELECTRONIC DATA CAPTURE Sophie McCallum, Director of Operations, Clinovo INTRODUCTION Electronic Data Capture (EDC) collects clinical trial data electronically rather than on paper.
More informationBatch Process Skid Solutions (Mixing & Blending skid)
Batch Process Skid Solutions (Mixing & Blending skid) Mixing & Blending Control System Solutions for OEMs This paper takes a closer look at the Batch Process Skid Solution for Process OEMs This paper provides
More informationIBM Tivoli Asset Management for IT
Cost-effectively manage the entire life cycle of your IT assets IBM Highlights Help control the costs of IT assets with a single product installation that tracks and manages hardware, software and related
More information4Sight Calibration Management Software
GE Measurement & Control Solutions 4Sight Calibration Management Software 4Sight calibration and maintenance management software provides visibility to the assets, data, and resources that affect maintenance,
More informationBiotechnology Manufacturing Analytics
Cory Brown Dermot McCaul Rob Kasprow, PhD SAP Adaptive Manufacturing Summit September 2009 Chicago, IL Biotechnology Manufacturing Analytics Vaccine Manufacturing Operations IT Account Manager Vaccine
More informationThe Piping System Model a New Life Cycle Document. Elements of the Piping System Model
Piping System Model as a Life Cycle Document White Paper Introduction When designing piping systems, a variety of documents are created providing the details necessary to design, purchase, build, and test
More informationProcess Safety Management Program
Process Safety Management Program Title: Compliance Guidelines for Operating Procedures Document #: PSM-SY-UN-014 Issued: 08/20/2014 Responsible Dept.: EHS Version: New Approved By: PSM Focus Group Page:
More informationFDA/Centers: your center training contact, who will submit it to the DHRD training officer.
DATE: September 9, 2011 FROM: John Shafer Director, Division of Human Resource Development (HFC-60) SUBJECT: COURSE ANNOUNCEMENT Biomanufacturing Principles and Processes Training (DG426, DG427, DG428,
More informationTailored Automation Solutions for Performance-Driven Machinery. Executive Overview... 3. Business Case for External Collaboration...
ARC WHITE PAPER By ARC Advisory Group JANUARY 2014 Tailored Automation Solutions for Performance-Driven Machinery Executive Overview... 3 Business Case for External Collaboration... 4 Tailoring the Automation
More informationMHRA GMP Data Integrity Definitions and Guidance for Industry March 2015
MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This
More informationIntroduction to Vicinity
White Paper September 9, 2002 Table of Contents Introduction to Vicinity... 1 Bill of Material (BOM) vs. Formula... 2 QC testing... 2 Unit of measure... 3 Lot tracking... 3 Hybrid manufacturing... 3 Vicinity
More informationGain efficiency in your process development with ÄKTA avant
Gain efficiency in your process development with ÄKTA avant gelifesciences.com Gain efficiency in your process development with ÄKTA avant Development of efficient manufacturing processes is a necessity
More informationINTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to
INTRODUCTION This book offers a systematic, ten-step approach, from the decision to validate to the assessment of the validation outcome, for validating configurable off-the-shelf (COTS) computer software
More informationZeta Automation. Automation for pharma industry. www.zeta-automation.de
Zeta Automation Automation for pharma industry www.zeta-automation.de About Zeta Automation Zeta Automation GmbH, based in Freising, Germany, is an associate of Zeta Holding GmbH based in Lieboch in Austria.
More informationThe Importance of Developing a High Yield of Product
European Antibody Congress Lyon, 3 rd November 2005 The Importance of Developing a High Yield of Product John Birch, Lonza Biologics plc Monoclonal Antibodies A Success Story Fastest growing segment of
More information4Improving Monitoring
4Improving Monitoring Powerful, flexible, open, scalable and adaptable to your needs A new way to monitoring and analyze the performance of you investment Full control when you need it! 4Improving SOLAR
More informationRavi Garcia Rdg88 Biological Engineering Johnson and Johnson Spring-Summer Co-op Job Summary I did my co-op at Janssen Pharmaceuticals, the
Ravi Garcia Rdg88 Biological Engineering Johnson and Johnson Spring-Summer Co-op Job Summary I did my co-op at Janssen Pharmaceuticals, the Pharmaceutical subsidiary of Johnson and Johnson. Within Janssen,
More informationGlobal Shared Support Service:
Global Shared Support Service: Leveraging expertise, sharing costs andderiving value Chandra Shekar Kakal Shared service in any field comes with an implicit assumption of reduced cost and improved efficiency.
More informationAssay Qualification Template for Host Cell Protein ELISA
Assay Qualification Template for Host Cell Protein ELISA Introduction: With ever increasing importance being placed on host cell protein (HCP) removal during the purification process, it is critical to
More informationExciting Trends in Bioprocessing
Exciting Trends in Bioprocessing Alfred Doig and Susan Dana Jones, Ph.D. April 20, 2015 BioProcess Technology Consultants, Inc. 12 Gill Street, Suite 5450 Woburn, MA 01801 Exciting Trends in Bioprocessing
More informationFrom Research Services and Process Development to GMP Manufacturing
From Research Services and Process Development to GMP Manufacturing P a r ag o n B i o s e r v i c e s, I n c. A contract research and GMP manufacturing organization (CMO) with a focus on the development
More informationSymantec Residency and Managed Services
Symantec Residency and Managed Services Flexible options for staff augmentation and IT out-tasking Symantec Global Services Confidence in a connected world. Symantec Residency and Managed Services provide
More informationRealizing the Benefits of Finite Capacity Scheduling to Manage Batch Production Systems
Presented at the WBF North American Conference Baltimore, MD, USA 30 April - 4 May 2007 67 Alexander Drive PO Box 12277 Research Triangle Park, NC 27709 +1.919.314.3970 Fax: +1.919.314.3971 E-mail: info@wbf.org
More informationSingle Step Clarification & Capture of a Recombinant Protein from E. coli Osmotic Shock by Crossflow Chromatography
www.natrixseparations.com Complex Separations Single Step Clarification & Capture of a Recombinant Protein from E. coli Osmotic Shock by Crossflow Chromatography AN1000 Summary Recombinant Shiga toxin
More informationA Real -Time Knowledge-Based System for Automated Monitoring and Fault Diagnosis of Batch Processes
A Real -Time Knowledge-Based System for Automated Monitoring and Fault Diagnosis of Batch Processes Eric Tatara, Cenk Ündey, Bruce Williams, Gülnur Birol and Ali Çinar Department of Chemical and Environmental
More informationDevelopment, Acquisition, Implementation, and Maintenance of Application Systems
Development, Acquisition, Implementation, and Maintenance of Application Systems Part of a series of notes to help Centers review their own Center internal management processes from the point of view of
More informationFlexibility in a Biotech Manufacturing Facility: An Options Analysis for Monoclonal Antibody Production
Flexibility in a Biotech Manufacturing Facility: An Options Analysis for Monoclonal Antibody Production ESD.71 Engineering Systems Analysis for Design Professor Richard de Neufville December 8, 2011 EXECUTIVE
More informationApplication Note. Purifying common light-chain bispecific antibodies using MCSGP. Summary
Application Note Purifying common light-chain bispecific antibodies using MCSGP Category Matrix Method Keywords Analytes ID Continuous chromatography, biochromatography Antibodies MCSGP Bispecific antibody,
More informationCall 2014: High throughput screening of therapeutic molecules and rare diseases
Call 2014: High throughput screening of therapeutic molecules and rare diseases The second call High throughput screening of therapeutic molecules and rare diseases launched by the French Foundation for
More informationClinPlus. Clinical Trial Management System (CTMS) Technology Consulting Outsourcing. Expedite trial design and study set-up
Technology Consulting Outsourcing ClinPlus Clinical Trial Management System (CTMS) Expedite trial design and study set-up Efficiently collect and manage patient and trial administration data Benefit from
More informationAutoSave. Achieving Part 11 Compliance. A White Paper
AutoSave Achieving Part 11 Compliance A White Paper Synopsis This whitepaper provides information related to FDA regulation 21 CFR Part 11 (Part 11) for organizations considering MDT software solutions.
More information_experience the commitment TM. Seek service, not just servers
The complete cloud Creating and preserving cloud savings, security and service quality transition planning and service management ABOUT THIS PAPER Creating and preserving cloud infrastructure savings,
More informationInstrument services for WAVE Bioreactor systems
GE Healthcare Life Sciences Instrument services for WAVE Bioreactor systems Share our depth of knowledge Service designed for your peace of mind GE Healthcare Life Sciences Services has over 50 years of
More informationAnswers to Review Questions
Tutorial 2 The Database Design Life Cycle Reference: MONASH UNIVERSITY AUSTRALIA Faculty of Information Technology FIT1004 Database Rob, P. & Coronel, C. Database Systems: Design, Implementation & Management,
More informationRefinery Equipment of Texas. Mini - Refinery Feasibility Overview
Mini - Refinery Feasibility Overview Introduction This paper is intended to provide information, answer questions, and assist the owner or project developer in making informed buying decisions. A mini-refinery
More informationRisk-Based Approach to 21 CFR Part 11
3109 W. Dr. Martin Luther King, Jr. Blvd., Suite 250 Tampa, FL 33607 USA Tel: 813/960-2105 Fax: 813/264-2816 www.ispe.org Risk-Based Approach to 21 CFR Part 11 The 21 CFR Part 11 regulation is a comprehensive
More informationTHE CLOUD: PROGRESS AND POTENTIAL
THE CLOUD: PROGRESS AND POTENTIAL The cloud has made a tremendous amount of progress in a relatively short time on the technological landscape. Cloud solutions faced doubts soon after their introduction,
More informationLean Kitting: A Case Study
Lean Kitting: A Case Study Ranko Vujosevic, Ph.D. Optimal Electronics Corporation Jose A. Ramirez, Larry Hausman-Cohen, and Srinivasan Venkataraman The University of Texas at Austin Department of Mechanical
More informationNext-Generation Facilities for Monoclonal Antibody Production
Advancing Development & Manufacturing Facilities Next-Generation Facilities for Monoclonal Antibody Production Niels Guldager ELECTRONICALLY REPRINTED FROM JULY 2009 The biopharmaceutical industry faces
More informationcan you effectively plan for the migration and management of systems and applications on Vblock Platforms?
SOLUTION BRIEF CA Capacity Management and Reporting Suite for Vblock Platforms can you effectively plan for the migration and management of systems and applications on Vblock Platforms? agility made possible
More informationData Management Software
Data Management Software ProdX Software Enhanced Productivity Superior Product Quality World Class Security Total Process Clarity ProdX Product Inspection Data Management Software 2 ProdX Data Management
More informationLuca Romagnoli, Ph.D. Business Development Manager
Modelli innovativi di produzione per lo sviluppo di un processo altamente qualitativo di farmaci biologici Luca Romagnoli, Ph.D. Business Development Manager BIOLOGICAL DRUGS - SOURCES Monoclonal antibodies
More informationHigh Availability for Non-Traditional Discrete and Process Applications Ensuring Continuous Operations With Increased Controller Reliability
GE Intelligent Platforms High Availability for Non-Traditional Discrete and Process Applications Ensuring Continuous Operations With Increased Controller Reliability High Availability for Non-Traditional
More informationData Mining Builds Process Understanding for Vaccine Manufacturing
Data Mining Builds Process Understanding for Vaccine Manufacturing WCBP 2009 Current Topics in Vaccine Development January 14, 2009 Julia O Neill, Principal Engineer Merck & Co., Inc. Global Vaccine Technology
More informationManufacturing process of biologics
Manufacturing process of biologics K. Ho Afssaps, France 2011 ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use 2011 ICH 1 Disclaimer:
More informationCloud Computing Safe Harbor or Wild West?
IT Best Practices Series Cloud Computing Safe Harbor or Wild West? With IT expenditures coming under increasing scrutiny, the cloud is being sold as an oasis of practical solutions. It s true that many
More informationWHITE PAPER OCTOBER 2014. Unified Monitoring. A Business Perspective
WHITE PAPER OCTOBER 2014 Unified Monitoring A Business Perspective 2 WHITE PAPER: UNIFIED MONITORING ca.com Table of Contents Introduction 3 Section 1: Today s Emerging Computing Environments 4 Section
More informationHydraulic Pipeline Application Modules PSI s Tools to Support Pipeline Operation
Hydraulic Pipeline Application Modules PSI s Tools to Support Pipeline Operation Inhalt 1 Leak Detection and Location Modules... 3 1.1 Dynamic Balance Leak Detection... 3 1.2 Transient Model Leak Detection...
More informationAccounts Payable Invoice Processing. White Paper
www.allstarss.com ACCELERATING Business Processes Accounts Payable Invoice Processing Table of Contents Table of Contents TABLE OF CONTENTS... I THE BUSINESS CHALLENGE... 2 Invoice Processing Costs...
More informationMonoclonal Antibody Production: Building the Platform. Andrew Clutterbuck Eden Biodesign Ltd.
Monoclonal Antibody Production: Building the Platform Andrew Clutterbuck Eden Biodesign Ltd. Questions Questions are encouraged throughout the presentation and can be asked by using the email address provided
More informationIN TOUGH ECONOMIC TIMES: 4 Key Considerations & 7 Creative Solutions for Immediate Savings
REDUCING THE COSTS OF CONTINUOUS OPERATING SCHEDULES IN TOUGH ECONOMIC TIMES: 4 Key Considerations & 7 Creative Solutions for Immediate Savings Bill Davis, Vice President of Operations INTRODUCTION When
More informationUnsurpassed Expertise In Labeling, Coding and Marking Means We Have Your Solution.
IDENTIFICATION AND TRACKING SOLUTIONS FROM ID TECHNOLOGY Unsurpassed Expertise In Labeling, Coding and Marking Means We Have Your Solution. LABEL PRINTERS & APPLICATORS LASER CODERS CIJ CODERS THERMAL
More informationOverview of Upstream and Downstream Processing of Biopharmaceuticals
Overview of Upstream and Downstream Processing of Biopharmaceuticals Ian Marison Professor of Bioprocess Engineering and Head of School of Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland
More informationBest-In-Class HR, Benefits, and Payroll Solutions for the Public Sector. trusted efficient responsive best practices
Best-In-Class HR, Benefits, and Payroll Solutions for the Public Sector trusted efficient responsive best practices The ADP Advantage Best practices are critical when you are challenged to do more with
More informationIntegrated Set of Applications
Oracle Payroll Oracle Payroll is a highly efficient, graphical, rules-based payroll management system that is designed to keep pace with the changing needs of your enterprise and workforce in order to
More informationValuation of Your Early Drug Candidate. By Linda Pullan, Ph.D. www.sharevault.com. Toll-free USA 800-380-7652 Worldwide 1-408-717-4955
Valuation of Your Early Drug Candidate By Linda Pullan, Ph.D. www.sharevault.com Toll-free USA 800-380-7652 Worldwide 1-408-717-4955 ShareVault is a registered trademark of Pandesa Corporation dba ShareVault
More informationBriefing for Doctors. Introduction. Electronic Prescribing. Electronic Prescribing:
Electronic Prescribing: Briefing for Doctors Electronic Prescribing Introduction Electronic prescribing (eprescribing) systems can help improve the safety and efficiency of healthcare by aiding the choice,
More information1735 East Bayshore Road, Suite 6B, Redwood City, CA 94063 408-252-2330 www.allegro.com
1735 East Bayshore Road, Suite 6B, Redwood City, CA 94063 408-252-2330 www.allegro.com Allegro is a software services, support, and development company headquartered in Redwood City, California. Founded
More informationSmart Operations Management Suite
Lifecycle Services for Syncade Operations Smart Operations Management Suite Service Data Sheet Lifecycle Services for Syncade Operations Smart Operations Management Suite Offering the Right Service at
More information"Bring Your Own Device" Brings its Own Challenges
6 June 2012 "Bring Your Own Device" Brings its Own Challenges By Susan McLean and Alistair Maughan The consumerisation of IT is the growing trend for information technology to emerge first in the consumer
More informationBuilding the Business Case for Automated Rapid Testing: Translating the benefits of rapid automated microbial testing into dollars saved
Building the Business Case for Automated Rapid Testing: Translating the benefits of rapid automated microbial testing into dollars saved A whitepaper by: Opportunities in Micro Quality Control According
More informationThe Sievers 900 Series TOC Analyzers
GE Water & Process Technologies Analytical Instruments The Sievers 900 Series TOC Analyzers imagination at work Delivering Next-Generation Ease of Use, Productivity, and Reliability The Sievers* 900 Series
More informationCALCET Company California Consulting Engineering & Technology 14895 E14th St. Ste 340, San Leandro, CA 94578 USA www.calcet.com
CALCET Company California Consulting Engineering & Technology 14895 E14th St. Ste 340, San Leandro, CA 94578 USA www.calcet.com ENGINEERING A PIVOTAL ROLE IN BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES
More informationAPPLICATION-SMART CONTROL
APPLICATION-SMART CONTROL SOLUTIONS Filling the automation void Today, customers and competitors are cutting back on process control expertise. Not so at MicroMod Automation. Instead, we re heavily investing
More informationKONDOR+ STRAIGHT THROUGH PROCESSING ONE PRODUCT, ONE DATABASE, ONE WORKFLOW: INCREASING EFFICIENCY AND REDUCING COSTS FROM THE FRONT TO THE BACK
KONDOR+ STRAIGHT THROUGH PROCESSING ONE PRODUCT, ONE DATABASE, ONE WORKFLOW: INCREASING EFFICIENCY AND REDUCING COSTS FROM THE FRONT TO THE BACK OFFICE Kondor+ Straight Through Processing KONDOR+ INTEGRATING
More informationIT@Intel. Comparing Multi-Core Processors for Server Virtualization
White Paper Intel Information Technology Computer Manufacturing Server Virtualization Comparing Multi-Core Processors for Server Virtualization Intel IT tested servers based on select Intel multi-core
More informationIncrease Business Velocity with Connected, Insightful, Cloud-Based Software
SAP Brief SAP Business ByDesign Objectives Increase Business Velocity with Connected, Insightful, Cloud-Based Software Integrated, cloud software that s quick to deploy and adapt Integrated, cloud software
More informationHigh-performance computing: Use the cloud to outcompute the competition and get ahead
High-performance computing: Use the cloud to outcompute the competition and get ahead High performance computing (HPC) has proved to be effective in offering highly analytical workloads the benefits of
More information